Skip to main content
Top
Published in: Archives of Orthopaedic and Trauma Surgery 11/2011

01-11-2011 | Orthopaedic Surgery

rhBMP-2 not alendronate combined with HA-TCP biomaterial and distraction osteogenesis enhance bone formation

Authors: Ming Ni, Gang Li, Pei-Fu Tang, Kai-Ming Chan, Yan Wang

Published in: Archives of Orthopaedic and Trauma Surgery | Issue 11/2011

Login to get access

Abstract

Introduction

The long treatment duration of distraction osteogenesis (DO) usually causes some complications such as re-fracture, non-union. We have previously demonstrated that the combined use of biomaterial with distraction osteogenesis technique can enhance bone formation and consolidation. This study further tested whether the use of biological agents such as rhBMP-2 or alendronate together with biomaterials in DO will further promote bone formation.

Methods

A 1.0-cm tibial shaft was removed in the left tibia of 30 rabbits. The 1.0-cm defect gap was reduced to 0.5 cm and the remaining 0.5-cm defect gap was filled with 0.5-cm restorable hydroxyapatite/tri-calcium phosphates (HA/TCP) cylindrical block. The animals were divided into three groups with the following added on the HA/TCP block: Group A 50 μl of saline, Group B 75 μg rhBMP-2 in 50 μl of saline, Group C 250 μg alendronate in 50 μl saline. The tibia was then fixed with unilateral lengthener and lengthening started 7 days after at a rate of 1.0 mm/day for 5 days. All animals were terminated at day 37 following surgery. The excised bone specimens were subject to micro-CT, mechanical testing and histological examinations.

Results

Bone mineral density and content were significantly higher in Groups A and B compared to Group C and the mechanical properties of the regenerates in Group B were highest. Micro-CT and histological examinations also confirmed that the regenerates in Group B had the most advanced bone formation, consolidation and remodeling comparing to other groups.

Conclusion

The combined use of rhBMP-2 with HA-TCP biomaterial in DO has significantly enhanced bone formation and consolidation than using the HA-TCP biomaterials alone, whereas the use of alendronate has inhibitory effects on bone formation.
Literature
1.
go back to reference Moseley CF (1989) Leg lengthening. A. review of 30 years. Clin Orthop 247:38–43PubMed Moseley CF (1989) Leg lengthening. A. review of 30 years. Clin Orthop 247:38–43PubMed
2.
go back to reference Dahl MT, Gulli B, Berg T (1994) Complications of limb lengthening. A learning curve. Clin Orthop 301:10–18PubMed Dahl MT, Gulli B, Berg T (1994) Complications of limb lengthening. A learning curve. Clin Orthop 301:10–18PubMed
3.
go back to reference Garcia CE, Olsen B, Ruiz Yague M et al (1992) Ilizarov technique: results and difficulties. Clin Orthop 283:116–123 Garcia CE, Olsen B, Ruiz Yague M et al (1992) Ilizarov technique: results and difficulties. Clin Orthop 283:116–123
4.
go back to reference Wang Y, Ni M, Tang PF et al (2009) Novel application of HA-TCP biomaterials in distraction osteogenesis shortened the lengthening time and promoted bone consolidation. J Orthop Res 27:477–482. doi:10.1002/jor.20782 PubMedCrossRef Wang Y, Ni M, Tang PF et al (2009) Novel application of HA-TCP biomaterials in distraction osteogenesis shortened the lengthening time and promoted bone consolidation. J Orthop Res 27:477–482. doi:10.​1002/​jor.​20782 PubMedCrossRef
12.
13.
go back to reference Wang Y, Wan C, Szoke G et al (2008) Local injection of thrombin-related peptide (TP508) in PPF/PLGA microparticles enhanced bone formation during distraction osteogenesis. J Orthop Res 26:539–546. doi:10.1002/jor.20495 PubMedCrossRef Wang Y, Wan C, Szoke G et al (2008) Local injection of thrombin-related peptide (TP508) in PPF/PLGA microparticles enhanced bone formation during distraction osteogenesis. J Orthop Res 26:539–546. doi:10.​1002/​jor.​20495 PubMedCrossRef
15.
go back to reference Yamaguchi A, Katagiri T, Ikeda T et al (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681–687PubMedCrossRef Yamaguchi A, Katagiri T, Ikeda T et al (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681–687PubMedCrossRef
16.
go back to reference Li G, Cui Y, Mcllmurray L et al (2005) rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. J Orthop Res 23:680–685PubMedCrossRef Li G, Cui Y, Mcllmurray L et al (2005) rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. J Orthop Res 23:680–685PubMedCrossRef
17.
go back to reference Li G (2004) New developments and insights learned from distraction osteogenesis. Curr Opin Orthop 15:325–330CrossRef Li G (2004) New developments and insights learned from distraction osteogenesis. Curr Opin Orthop 15:325–330CrossRef
18.
go back to reference Bergstrom JD, Bostedor RG, Masarachia PJ (2000) Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 373:231–241PubMedCrossRef Bergstrom JD, Bostedor RG, Masarachia PJ (2000) Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 373:231–241PubMedCrossRef
20.
go back to reference Greiner SH, Wildemann B, Back DA, Alidoust M, Schwabe P, Haas NP, Schmidmaier G (2008) Local application of zoledronic acid incorporated in a poly(d, l-lactide)-coated implant accelerates fracture healing in rats. Acta Orthop 79(5):717–725PubMedCrossRef Greiner SH, Wildemann B, Back DA, Alidoust M, Schwabe P, Haas NP, Schmidmaier G (2008) Local application of zoledronic acid incorporated in a poly(d, l-lactide)-coated implant accelerates fracture healing in rats. Acta Orthop 79(5):717–725PubMedCrossRef
21.
go back to reference Greiner S, Kadow-Romacker A, Wildemann B, Schwabe P, Schmidmaier G (2007) Bisphosphonates incorporated in a poly(d, l-lactide) implant coating inhibit osteoclast like cells in vitro. J Biomed Mater Res 83(4):1184–1191CrossRef Greiner S, Kadow-Romacker A, Wildemann B, Schwabe P, Schmidmaier G (2007) Bisphosphonates incorporated in a poly(d, l-lactide) implant coating inhibit osteoclast like cells in vitro. J Biomed Mater Res 83(4):1184–1191CrossRef
Metadata
Title
rhBMP-2 not alendronate combined with HA-TCP biomaterial and distraction osteogenesis enhance bone formation
Authors
Ming Ni
Gang Li
Pei-Fu Tang
Kai-Ming Chan
Yan Wang
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Archives of Orthopaedic and Trauma Surgery / Issue 11/2011
Print ISSN: 0936-8051
Electronic ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-011-1357-7

Other articles of this Issue 11/2011

Archives of Orthopaedic and Trauma Surgery 11/2011 Go to the issue